3d打印在药学中的应用综述

B. A
{"title":"3d打印在药学中的应用综述","authors":"B. A","doi":"10.23880/beba-16000191","DOIUrl":null,"url":null,"abstract":"3D printing also known as additive manufacturing which involves manufacturing of three dimensional objects by layering.3D printing includes layering materials, like plastics, composites or bio-materials to create objects that variety in shape, length, tension and color. This 3D printing generation has intense flexibility in what may be published. 3D printing has the capability to revolutionize the pharmaceutical manufacturing enterprise. Technologies currently being evaluated for use within the 3D printing of prescribed drugs, and the paintings of key market gamers to increase and increase their programs from studies to commercial. Close up of a 3D printing head approximately to begin a print at the printing mattress. The healthcare desires of the populace, and the therapeutics we use to deal with them, are changing. Though generics are undeniably critical, there’s a significant shift towards personalization and customization of remedy – inspired by using the adoption and enhancement of omics technology in healthcare. 3D Printing makes use of software that slices the 3D version into layers (0.01mm thick or less in most cases). Each layer is then traced onto the build plate by the printer, as soon as the pattern is finished, the construct plate is diminished and the subsequent layer is introduced on pinnacle of the previous one. 3D printing generation will revolutionize the pharmaceutical production style and system strategies. However, there's still a enormous barrier to make sure that 3D printed medicines have the same efficacy, protection, and balance as the pharmaceuticals conventionally manufactured by the Pharmaceutical Industry. Regarding the established order of recommendations, laws, first-class systems and protection of use and intake of 3D published drug treatments, it’s miles a top notch assignment for the regulatory authorities entailing great barriers, given the traditional requirements by way of the pharmaceutical sector.","PeriodicalId":8995,"journal":{"name":"Bioequivalence & Bioavailability International Journal","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Review on Various Aspects of 3-D Printing in Pharmacy\",\"authors\":\"B. A\",\"doi\":\"10.23880/beba-16000191\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"3D printing also known as additive manufacturing which involves manufacturing of three dimensional objects by layering.3D printing includes layering materials, like plastics, composites or bio-materials to create objects that variety in shape, length, tension and color. This 3D printing generation has intense flexibility in what may be published. 3D printing has the capability to revolutionize the pharmaceutical manufacturing enterprise. Technologies currently being evaluated for use within the 3D printing of prescribed drugs, and the paintings of key market gamers to increase and increase their programs from studies to commercial. Close up of a 3D printing head approximately to begin a print at the printing mattress. The healthcare desires of the populace, and the therapeutics we use to deal with them, are changing. Though generics are undeniably critical, there’s a significant shift towards personalization and customization of remedy – inspired by using the adoption and enhancement of omics technology in healthcare. 3D Printing makes use of software that slices the 3D version into layers (0.01mm thick or less in most cases). Each layer is then traced onto the build plate by the printer, as soon as the pattern is finished, the construct plate is diminished and the subsequent layer is introduced on pinnacle of the previous one. 3D printing generation will revolutionize the pharmaceutical production style and system strategies. However, there's still a enormous barrier to make sure that 3D printed medicines have the same efficacy, protection, and balance as the pharmaceuticals conventionally manufactured by the Pharmaceutical Industry. Regarding the established order of recommendations, laws, first-class systems and protection of use and intake of 3D published drug treatments, it’s miles a top notch assignment for the regulatory authorities entailing great barriers, given the traditional requirements by way of the pharmaceutical sector.\",\"PeriodicalId\":8995,\"journal\":{\"name\":\"Bioequivalence & Bioavailability International Journal\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bioequivalence & Bioavailability International Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23880/beba-16000191\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioequivalence & Bioavailability International Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23880/beba-16000191","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

3D打印也被称为增材制造,它涉及通过分层制造三维物体。3D打印包括分层材料,如塑料、复合材料或生物材料,以创建形状、长度、张力和颜色各异的物体。这一代3D打印在可能出版的内容上具有很强的灵活性。3D打印有能力彻底改变制药企业。目前正在评估用于处方药3D打印的技术,以及主要市场参与者的绘画,以增加和增加他们的项目从研究到商业。3D打印头的近景,大约在打印床垫处开始打印。民众对医疗保健的需求,以及我们用来应对这些需求的治疗方法,都在发生变化。尽管仿制药无疑是至关重要的,但由于在医疗保健中采用和增强组学技术,治疗方法正在向个性化和定制化转变。3D打印利用软件将3D版本切片成层(大多数情况下厚度小于0.01毫米)。然后,每一层都由打印机描摹到构建板上,一旦图案完成,构建板就会减少,然后在前一层的顶峰上引入下一层。3D打印一代将彻底改变制药生产方式和系统策略。然而,要确保3D打印药物具有与制药业传统生产的药物相同的功效、保护和平衡,仍然存在巨大的障碍。考虑到制药行业的传统要求,关于建议、法律、一流系统和保护3D出版药物治疗的使用和摄入的既定顺序,这对监管机构来说是一项艰巨的任务,存在巨大的障碍。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Review on Various Aspects of 3-D Printing in Pharmacy
3D printing also known as additive manufacturing which involves manufacturing of three dimensional objects by layering.3D printing includes layering materials, like plastics, composites or bio-materials to create objects that variety in shape, length, tension and color. This 3D printing generation has intense flexibility in what may be published. 3D printing has the capability to revolutionize the pharmaceutical manufacturing enterprise. Technologies currently being evaluated for use within the 3D printing of prescribed drugs, and the paintings of key market gamers to increase and increase their programs from studies to commercial. Close up of a 3D printing head approximately to begin a print at the printing mattress. The healthcare desires of the populace, and the therapeutics we use to deal with them, are changing. Though generics are undeniably critical, there’s a significant shift towards personalization and customization of remedy – inspired by using the adoption and enhancement of omics technology in healthcare. 3D Printing makes use of software that slices the 3D version into layers (0.01mm thick or less in most cases). Each layer is then traced onto the build plate by the printer, as soon as the pattern is finished, the construct plate is diminished and the subsequent layer is introduced on pinnacle of the previous one. 3D printing generation will revolutionize the pharmaceutical production style and system strategies. However, there's still a enormous barrier to make sure that 3D printed medicines have the same efficacy, protection, and balance as the pharmaceuticals conventionally manufactured by the Pharmaceutical Industry. Regarding the established order of recommendations, laws, first-class systems and protection of use and intake of 3D published drug treatments, it’s miles a top notch assignment for the regulatory authorities entailing great barriers, given the traditional requirements by way of the pharmaceutical sector.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信